Clarity in cell line development

Solentim and SAL Scientific announce partnership for novel growth supplements in cell line development

Solentim, the global leader in cell line development (CLD) imaging instrumentation, and SAL Scientific, a leading provider of growth enhancing animal-free cell culture reagents, are pleased to announce a new strategic partnership. The collaboration will further optimise CLD workflow by supplying novel supplements which substantially improve cell growth. Solentim will act as the exclusive distributor for …

Read more Solentim and SAL Scientific announce partnership for novel growth supplements in cell line development

Valitacell and Solentim secure €3.5m funding to optimise the development of new biologics and cell therapies

A consortium, consisting of Valitacell, Solentim and Microcoat, has been awarded €2.5million under the highly competitive H2020 Fast Track to Innovation (FTI) initiative, and a further €1million from other sources Solentim and Valitacell announce a total of €3.5m funding to produce an integrated platform to deposit, culture, profile and select optimal cells for the manufacture of life-saving …

Read more Valitacell and Solentim secure €3.5m funding to optimise the development of new biologics and cell therapies

Valitacell and Solentim announce collaboration to accelerate discovery and development of biologic drugs and advanced cell therapies

  21st February 2019: Valitacell, a biotechnology company transforming cell-based manufacturing, and Solentim, a global leader in cell line development instrumentation, today announced a new collaboration to enable earlier identification of biological candidates and to accelerate the development of breakthrough medicines. Valitacell’s novel in-line analytical profiling technologies and its data-driven/machine learning approach, together with Solentim’s …

Read more Valitacell and Solentim announce collaboration to accelerate discovery and development of biologic drugs and advanced cell therapies

Solentim and ATUM announce technology collaboration to enable rapid, high expression, stable cell line development

NEWS – Bournemouth, UK – 14th January 2019: Solentim, a global leader in cell line development instrumentation, and bioengineering company ATUM, today announced a technology partnering and collaboration agreement. This agreement creates the most efficient cell line development solution for biotherapeutic drug developers yet, by integrating Solentim’s VIPS™ (verified in-situ plate seeding) hardware for isolating single …

Read more Solentim and ATUM announce technology collaboration to enable rapid, high expression, stable cell line development

Solentim Strengthens Team | Claire Richards appointed Head of Biological Science

NEWS – Bournemouth, UK – 10th January 2019: Solentim, the innovator and leader in Cell Line Development instrumentation, is pleased to announce the appointment of Claire Richards as their new Head of Biological Science. Claire Richards began her career at the Wellcome Trust Sanger Institute/Cambridge University where she did her PhD in the Cancer Genome …

Read more Solentim Strengthens Team | Claire Richards appointed Head of Biological Science

Solentim at the Palace

This week, members of Solentim’s management team enjoyed the privileged experience of visiting Buckingham Palace. The invitation to a private reception at the Palace followed Solentim’s success in winning two Queen’s Awards for Enterprise, announced in April, the first for Innovation and the second for International Trade. The reception was hosted by The Prince of …

Read more Solentim at the Palace